CSIMarket
 
Teleflex Incorporated  (TFX)
 

Teleflex Incorporated's Fourth Quarter Earnings: Revenue Up, But Profits Down

Challenges and Opportunities: A Closer Look at Teleflex Incorporated*s Q4 Financial Results


Published Feb 24 2024 / Modified Feb 24 2024
CSIMarket Team / CSIMarket.com


Medical_ultrasound_examination_pdTeleflex Incorporated's latest financial report for the three months ending December 31, 2023, showed a mixed bag of results for investors.
Despite a revenue improvement of 2.094%, the company experienced a significant income decline of -60.67% compared to the same quarter the previous year.
Net profits also fell by -60.42% in this period.

The company's earnings per share (EPS) dropped by -77.34% from the previous quarter, coming in at $0.66 per share.
However, revenue grew by 3.692% to $773.87 million.
Operating earnings fell by -35.87% to $82.468 million, narrowing the operating margin to 10.66%. Teleflex Incorporated also saw a build-up in inventories and accounts receivable, signaling rising demand for their products.

Looking at the financial results for the full year of 2023, Teleflex Incorporated reported revenue of $2.97 billion and a bottom-line of $356.33 million.
EPS decreased by -1.95% to $7.53 per share from the previous year.

In light of these results, investors may be questioning the company's future performance.
Teleflex Incorporated's shares have dropped by -4.08% in the past 30 days, bringing the year-to-date performance to -5.05%. However, the shares are currently trading 1.9% above their 52-week average on the NYSE.

Teleflex Incorporated recently announced a quarterly dividend payment of $0.34 per share of common stock, payable on March 15, 2024.
With a dividend payout ratio of 15.81%, some investors may be wondering if the company will increase its dividend in the near future.

Liam Kelly, Chairman, President, and CEO of Teleflex Incorporated, is scheduled to speak at the 45th Annual Raymond James Institutional Investors Conference in March, which may provide further insight into the company's future plans and performance.
Investors should keep a close eye on Teleflex Incorporated's developments and announcements in the coming months.



Teleflex Incorporated's Revenue per Employee

Teleflex Incorporated's Dividend Comparisons



Other TFX's news

Revolutionizing Supply Chain Management Teleflex Partners with o9 for Integrated Business Planning

for the Teleflex?s Titan SGS Stapler Enhances Bariatric Surgery with Enhanced Outcomes and Efficie...

Teleflex Incorporated Faces Sell-off Amid Broader Market Declines and Competitive Challenges,

Teleflex Incorporated Reports Steady 0.893% Revenue Growth Amidst Income Challenges in Q2 2024

Teleflex Incorporates Shareholder Value in Q3 2024: A Strategic Dividend Increase Amidst Competitive Performance Landscape

Teleflex Advances Medical Frontiers with Novel Cardiology and Vascular Access Solutions

Teleflex and Premier, Inc. Forge Alliance Revolutionary Hemostatic Products Now Available at Exclusive Rates fo...

Teleflex Enhances Medical Technologies with New Antimicrobial Center, Temporary Pacing Guidewire, and Tissue Co...

Teleflex Inc. Faces Challenges in Stock Performance despite Positive Market Trends

Teleflex Recalls Balloon Catheter Kits, Christopher Gleason Named CEO of Moximed Inc.

Wayne, Pennsylvania - Teleflex Incorporated, a global leader in medical technologies, is making waves in the healthcare industry with its groundbreaking products and commitment to environmental sustainability. With the introduction of the Arrow EZ-IO Intraosseous Access Procedure Tray and the UroLift 2 System with Advanced Tissue Control, Teleflex continues to enhance patient care while reducing...

Teleflex Incorporated Surpasses Expectations with $41.55 Million Tax Provision Boost

Teleflex Incorporated*s Fourth Quarter Earnings: Revenue Up, But Profits Down

Teleflex Incorporated Surpasses Expectations with Remarkable Revenue Growth in Latest Fiscal Quarter

EPS surged by 5.38 % at the Teleflex Incorporated over the fiscal interval closing July 02 2023

Teleflex Incorporated*s Revenue Continues to Soar as Earnings per Share Decline in the February to April 02, 2023 period



Other TFX's news

Revolutionizing Supply Chain Management Teleflex Partners with o9 for Integrated Business Planning

for the Teleflex?s Titan SGS Stapler Enhances Bariatric Surgery with Enhanced Outcomes and Efficie...

Teleflex Incorporated Faces Sell-off Amid Broader Market Declines and Competitive Challenges,

Teleflex Incorporated Reports Steady 0.893% Revenue Growth Amidst Income Challenges in Q2 2024

Teleflex Incorporates Shareholder Value in Q3 2024: A Strategic Dividend Increase Amidst Competitive Performance Landscape

Teleflex Advances Medical Frontiers with Novel Cardiology and Vascular Access Solutions

Teleflex and Premier, Inc. Forge Alliance Revolutionary Hemostatic Products Now Available at Exclusive Rates fo...

Teleflex Enhances Medical Technologies with New Antimicrobial Center, Temporary Pacing Guidewire, and Tissue Co...

Teleflex Inc. Faces Challenges in Stock Performance despite Positive Market Trends

Teleflex Recalls Balloon Catheter Kits, Christopher Gleason Named CEO of Moximed Inc.

Wayne, Pennsylvania - Teleflex Incorporated, a global leader in medical technologies, is making waves in the healthcare industry with its groundbreaking products and commitment to environmental sustainability. With the introduction of the Arrow EZ-IO Intraosseous Access Procedure Tray and the UroLift 2 System with Advanced Tissue Control, Teleflex continues to enhance patient care while reducing...

Teleflex Incorporated Surpasses Expectations with $41.55 Million Tax Provision Boost

Teleflex Incorporated*s Fourth Quarter Earnings: Revenue Up, But Profits Down

Teleflex Incorporated Surpasses Expectations with Remarkable Revenue Growth in Latest Fiscal Quarter

EPS surged by 5.38 % at the Teleflex Incorporated over the fiscal interval closing July 02 2023

Teleflex Incorporated*s Revenue Continues to Soar as Earnings per Share Decline in the February to April 02, 2023 period



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com